Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells

被引:19
作者
An, S [1 ]
Yap, D [1 ]
Knox, KA [1 ]
机构
[1] UNIV OXFORD, DEPT BIOCHEM, OXFORD OX1 3QU, ENGLAND
关键词
D O I
10.1006/cimm.1997.1211
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The proliferation and survival of a B cell population is necessarily tightly controlled to prevent the arisal of malignancy or autoimmunity. The expansion or elimination of a B cell clone is determined through a complex interaction of the tumour necrosis factor receptor/nerve growth factor receptor family members CD40 and Fas, which are expressed on the B cell surface, with their respective physiological ligands (CD40L and Fast) expressed on the surface of CD4(+) T cells. The regulation of B cell growth by signals transduced through CD40 and Fas contributes to the maintenance of peripheral tolerance and likely takes place and in the germinal centres (GC) of secondary lymphoid tissues, In this study, we investigate the relationship between the expression of Fas and B cell survival following engagement of CD40 and Fas in the Epstein-Barr virus-genome-negative Ramos-Burkitt lymphoma (Ramos-BL) B cell line model of GC B lymphocyte selection during maturation of the humoral immune response, We now present evidence that Ramos-BL B cells constitutively express both Fas and Fast on their surface and that expression of Fas, but not Fast, is enhanced following ligation of CD40, Coligation of CD40 and Fas, triggers for growth inhibition, activation of the interleukin-1 beta-converting enzyme, now caspase, family member CPP32 (caspase-3) but not Ich-1(L) (caspase-2), cleavage of its death substrate poly(ADP-ribose) polymerase, and apoptosis from the G(1) phase of cell cycle; engagement of Fas alone fails to trigger for growth inhibition and apoptosis but enhances AgR-mediated cellular death. This CD40-potentiated Fas-triggered growth inhibition and apoptosis occurs in the presence of CD40-induced expression of the anti-apoptotic proteins Bcl-x(L) and Bcl-2, Taken together, these data indicate that ligation of CD40 facilitates efficient coupling of Fas to the caspase-mediated pathway of apoptosis. (C) 1997 Academic Press.
引用
收藏
页码:139 / 152
页数:14
相关论文
共 50 条
[1]   Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[2]   Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP [J].
An, SK ;
Knox, KA .
FEBS LETTERS, 1996, 386 (2-3) :115-122
[3]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[4]   CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].
BOISE, LH ;
MINN, AJ ;
NOEL, PJ ;
JUNE, CH ;
ACCAVITTI, MA ;
LINDSTEN, T ;
THOMPSON, CB .
IMMUNITY, 1995, 3 (01) :87-98
[5]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[6]   THE ROLE OF BCL-X(L) IN CD40-MEDIATED RESCUE FROM ANTI-MU-INDUCED APOPTOSIS IN WEHI-231 B-LYMPHOMA-CELLS [J].
CHOI, MSK ;
BOISE, LH ;
GOTTSCHALK, AR ;
QUINTANS, J ;
THOMPSON, CB ;
KLAUS, GGB .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) :1352-1357
[7]  
CLEARY AM, 1995, J IMMUNOL, V155, P3329
[8]   CD40 LIGAND MUTATIONS IN X-LINKED IMMUNODEFICIENCY WITH HYPER-IGM [J].
DISANTO, JP ;
BONNEFOY, JY ;
GAUCHAT, JF ;
FISCHER, A ;
DESAINTBASILE, G .
NATURE, 1993, 361 (6412) :541-543
[9]  
FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045
[10]  
FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737